Eton secures US patent for diabetes insipidus treatment
Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for diabetes insipidus.
Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for diabetes insipidus.
What's Your Reaction?
